BACKGROUND:
The purpose of this prospective, randomized study was to evaluate the clinical and radiographic results associated with proximally porous-coated titanium stems that were identical in geometry but differed with regard to proximal surface treatment (with or without hydroxyapatite coating).

METHODS:
A prospective, randomized study was performed to evaluate fifty patients (100 hips) who had undergone sequential bilateral primary total hip replacement. A proximally porous-coated titanium stem with hydroxyapatite coating was implanted on one side and a proximally porous-coated titanium stem without hydroxyapatite coating was implanted on the other side during the same operative setting in all fifty patients. A cementless acetabular component made of titanium was used in all hips. There were thirty-six men and fourteen women; the mean age at the time of the operation was 45.3 years. The mean duration of follow-up was 6.6 years. Clinical and radiographic evaluations were performed preoperatively; at six weeks; at three, six, and twelve months; and yearly thereafter.

RESULTS:
The Harris hip scores in the hydroxyapatite-coated group (mean, 94 points) and non-hydroxyapatite-coated group (mean, 92 points) were similar at the final follow-up examination. The prevalence of transient pain in the thigh was 4% in each group. No acetabular or femoral component demonstrated aseptic loosening. Bone-remodeling patterns, including calcar atrophy, were similar in the two groups. No acetabular or femoral osteolysis was seen.

CONCLUSIONS:
At a mean of 6.6 years postoperatively, the clinical and radiographic results associated with proximally porous-coated femoral prostheses with identical geometries that differed only with regard to the presence or absence of hydroxyapatite coating were similar.





Polls results
1

On a scale of 1 to 10, rate how much this article will change your clinical practice?

NO change
BIG change
84% Article relates to my practice (11/13)
15% Article does not relate to my practice (2/13)
0% Undecided (0/13)
2

Will this article lead to more cost-effective healthcare?

69% Yes (9/13)
7% No (1/13)
23% Undecided (3/13)
3

Was this article biased? (commercial or personal)

7% Yes (1/13)
84% No (11/13)
7% Undecided (1/13)
4

What level of evidence do you think this article is?

53% Level 1 (7/13)
0% Level 2 (0/13)
30% Level 3 (4/13)
15% Level 4 (2/13)
0% Level 5 (0/13)